JMC, B., Y, P., LD, P., TG, d. M., HS, B., J, L., . . . K, S. (2022). Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in Trypanosoma cruzi-infected cardiac cells. Frontiers in cellular and infection microbiology, 12, 975931. https://doi.org/10.3389/fcimb.2022.975931
Chicago Style (17th ed.) CitationJMC, Barbosa, Pedra-Rezende Y, Pereira LD, de Melo TG, Barbosa HS, Lannes-Vieira J, de Castro SL, Daliry A, and Salomão K. "Benznidazole and Amiodarone Combined Treatment Attenuates Cytoskeletal Damage in Trypanosoma Cruzi-infected Cardiac Cells." Frontiers in Cellular and Infection Microbiology 12 (2022): 975931. https://doi.org/10.3389/fcimb.2022.975931.
MLA (9th ed.) CitationJMC, Barbosa, et al. "Benznidazole and Amiodarone Combined Treatment Attenuates Cytoskeletal Damage in Trypanosoma Cruzi-infected Cardiac Cells." Frontiers in Cellular and Infection Microbiology, vol. 12, 2022, p. 975931, https://doi.org/10.3389/fcimb.2022.975931.